This international ITP registry study through the South Eastern Sydney Local Health District and GlaxoSmithLine is looking to prospectively enrol newly diagnosed adult patients with ITP to follow them for a period of two years. This study is recruiting ITP patients over the age of 18 years from one of the international designated participating centres. The goal of this registry is to learn more about the clinical characteristics of ITP, including the prevalence of the disease in various places, the incidence of co-morbidities, treatment patterns, and possible adverse outcomes (resulting from treatment or disease). Multi-site participation of this registry project will be rolled out in stages.

Australia, Korea, Taiwan, Singapore, Malaysia, Japan, Thailand, and Turkey.

https://www.clinicaltrials.gov/ct2/show/NCT01970189?recrs=ab&cond=Immune+Thrombocytopenia&draw=2&rank=47

Recruiting